Literature DB >> 18765652

Distinct muscle imaging patterns in myofibrillar myopathies.

D Fischer1, R A Kley, K Strach, C Meyer, T Sommer, K Eger, A Rolfs, W Meyer, A Pou, J Pradas, C M Heyer, A Grossmann, A Huebner, W Kress, J Reimann, R Schröder, B Eymard, M Fardeau, B Udd, L Goldfarb, M Vorgerd, M Olivé.   

Abstract

OBJECTIVE: To compare muscle imaging findings in different subtypes of myofibrillar myopathies (MFM) in order to identify characteristic patterns of muscle alterations that may be helpful to separate these genetic heterogeneous muscular disorders.
METHODS: Muscle imaging and clinical findings of 46 patients with MFM were evaluated (19 desminopathy, 12 myotilinopathy, 11 filaminopathy, 1 alphaB-crystallinopathy, and 3 ZASPopathy). The data were collected retrospectively in 43 patients and prospectively in 3 patients.
RESULTS: In patients with desminopathy, the semitendinosus was at least equally affected as the biceps femoris, and the peroneal muscles were never less involved than the tibialis anterior (sensitivity of these imaging criteria to detect desminopathy in our cohort 100%, specificity 95%). In most of the patients with myotilinopathy, the adductor magnus showed more alterations than the gracilis muscle, and the sartorius was at least equally affected as the semitendinosus (sensitivity 90%, specificity 93%). In filaminopathy, the biceps femoris and semitendinosus were at least equally affected as the sartorius muscle, and the medial gastrocnemius was more affected than the lateral gastrocnemius. The semimembranosus mostly showed more alterations than the adductor magnus (sensitivity 88%, specificity 96%). Early adult onset and cardiac involvement was most often associated with desminopathy. In patients with filaminopathy, muscle weakness typically beginning in the 5th decade of life was mostly pronounced proximally, while late adult onset (>50 years) with distal weakness was more often present in myotilinopathy.
CONCLUSIONS: Muscle imaging in combination with clinical data may be helpful for separation of distinct myofibrillar myopathy subtypes and in scheduling of genetic analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765652      PMCID: PMC2583436          DOI: 10.1212/01.wnl.0000324927.28817.9b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Different early pathogenesis in myotilinopathy compared to primary desminopathy.

Authors:  Dirk Fischer; Christoph S Clemen; Montse Olivé; Isidro Ferrer; Bertrand Goudeau; Udo Roth; Petra Badorf; Mike P Wattjes; Götz Lutterbey; Thomas Kral; Peter F M van der Ven; Dieter O Fürst; Patrick Vicart; Lev G Goldfarb; Monica Moza; Olli Carpen; Julia Reichelt; Rolf Schröder
Journal:  Neuromuscul Disord       Date:  2006-05-08       Impact factor: 4.296

2.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.

Authors:  Matthias Vorgerd; Peter F M van der Ven; Vera Bruchertseifer; Thomas Löwe; Rudolf A Kley; Rolf Schröder; Hanns Lochmüller; Mirko Himmel; Katrin Koehler; Dieter O Fürst; Angela Huebner
Journal:  Am J Hum Genet       Date:  2005-05-31       Impact factor: 11.025

3.  Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro.

Authors:  Harald Bär; Dirk Fischer; Bertrand Goudeau; Rudolf A Kley; Christoph S Clemen; Patrick Vicart; Harald Herrmann; Matthias Vorgerd; Rolf Schröder
Journal:  Hum Mol Genet       Date:  2005-03-30       Impact factor: 6.150

4.  Hsp27-2D-gel electrophoresis is a diagnostic tool to differentiate primary desminopathies from myofibrillar myopathies.

Authors:  Christoph S Clemen; Dirk Fischer; Udo Roth; Stéphanie Simon; Patrick Vicart; Kanefusa Kato; Anna M Kaminska; Matthias Vorgerd; Lev G Goldfarb; Bruno Eymard; Norma B Romero; Bertrand Goudeau; Thomas Eggermann; Klaus Zerres; Angelika A Noegel; Rolf Schröder
Journal:  FEBS Lett       Date:  2005-07-04       Impact factor: 4.124

5.  Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.

Authors:  Heinz Jungbluth; Mark R Davis; Clemens Müller; Serena Counsell; Joanna Allsop; Arijit Chattopadhyay; Sonia Messina; Eugenio Mercuri; Nigel G Laing; Caroline A Sewry; Graeme Bydder; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2004-12       Impact factor: 4.296

6.  Myotilinopathy: refining the clinical and myopathological phenotype.

Authors:  Montse Olivé; Lev G Goldfarb; Alexey Shatunov; Dirk Fischer; Isidro Ferrer
Journal:  Brain       Date:  2005-06-09       Impact factor: 13.501

7.  Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.

Authors:  Dirk Fischer; Muriel Herasse; Marc Bitoun; Héctor M Barragán-Campos; Jacques Chiras; Pascal Laforêt; Michel Fardeau; Bruno Eymard; Pascale Guicheney; Norma B Romero
Journal:  Brain       Date:  2006-04-03       Impact factor: 13.501

8.  The enlarging spectrum of desminopathies: new morphological findings, eastward geographic spread, novel exon 3 desmin mutation.

Authors:  Alexandra Vrabie; Lev G Goldfarb; Alexey Shatunov; Andrea Nägele; Peter Fritz; Ingo Kaczmarek; Hans H Goebel
Journal:  Acta Neuropathol       Date:  2005-03-10       Impact factor: 17.088

9.  Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.

Authors:  J Berciano; E Gallardo; R Domínguez-Perles; E Gallardo; A García; R García-Barredo; O Combarros; J Infante; I Illa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-13       Impact factor: 10.154

10.  Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs.

Authors:  Dirk Fischer; Maggie C Walter; Kristina Kesper; Jens A Petersen; Stefania Aurino; Vincenzo Nigro; Christian Kubisch; Thomas Meindl; Hanns Lochmüller; Kai Wilhelm; Horst Urbach; Rolf Schröder
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

View more
  60 in total

Review 1.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

2.  Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy.

Authors:  Montse Olivé; Zagaa Odgerel; Amaia Martínez; Juan José Poza; Federico García Bragado; Ramón J Zabalza; Ivonne Jericó; Laura Gonzalez-Mera; Alexey Shatunov; Hee Suk Lee; Judith Armstrong; Elías Maraví; Maria Ramos Arroyo; Jordi Pascual-Calvet; Carmen Navarro; Carmen Paradas; Mariano Huerta; Fabian Marquez; Eduardo Gutierrez- Rivas; Adolf Pou; Isidre Ferrer; Lev G Goldfarb
Journal:  Neuromuscul Disord       Date:  2011-06-14       Impact factor: 4.296

3.  Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late-onset cerebellar ataxia.

Authors:  Giorgio Tasca; Zagaa Odgerel; Mauro Monforte; Stefania Aurino; Nigel F Clarke; Leigh B Waddell; Bjarne Udd; Enzo Ricci; Lev G Goldfarb
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

4.  Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report.

Authors:  Yingyin Liang; Guidian Li; Songlin Chen; Rongxing He; Xiangxue Zhou; Yingming Chen; Xue Xu; Ronglan Zhu; Cheng Zhang
Journal:  Biomed Rep       Date:  2017-06-29

5.  Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.

Authors:  Arne Fischmann; Monika Gloor; Susanne Fasler; Tanja Haas; Rachele Rodoni Wetzel; Oliver Bieri; Stephan Wetzel; Karl Heinimann; Klaus Scheffler; Dirk Fischer
Journal:  J Neurol       Date:  2011-02-22       Impact factor: 4.849

6.  Combined quantification of fatty infiltration, T 1-relaxation times and T 2*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients.

Authors:  Benjamin Leporq; Arnaud Le Troter; Yann Le Fur; Emmanuelle Salort-Campana; Maxime Guye; Olivier Beuf; Shahram Attarian; David Bendahan
Journal:  MAGMA       Date:  2017-03-22       Impact factor: 2.310

7.  Quantitative MRI can detect subclinical disease progression in muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Susanne Fasler; Monika Gloor; Oliver Bieri; Ueli Studler; Dirk Fischer
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

8.  LMNA-Related Muscular Dystrophy with Clinical Intrafamilial Variability.

Authors:  Ana Cotta; Julia F Paim; Elmano Carvalho; Jaquelin Valicek; Antonio L da Cunha Junior; Monica M Navarro; Antonio P Vargas; Maria I Lima; Camila F de Almeida; Reinaldo I Takata; Mariz Vainzof
Journal:  J Mol Neurosci       Date:  2019-08-13       Impact factor: 3.444

9.  Muscle MRI in muscular dystrophies.

Authors:  Jordi Díaz-Manera; Jaume Llauger; Eduard Gallardo; Isabel Illa
Journal:  Acta Myol       Date:  2015-12

10.  Filamin C-related myopathies: pathology and mechanisms.

Authors:  Dieter O Fürst; Lev G Goldfarb; Rudolf A Kley; Matthias Vorgerd; Montse Olivé; Peter F M van der Ven
Journal:  Acta Neuropathol       Date:  2012-10-30       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.